Compare CHT & MDLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CHT | MDLN |
|---|---|---|
| Founded | 1996 | 1966 |
| Country | Taiwan | United States |
| Employees | N/A | 45000 |
| Industry | Telecommunications Equipment | Medical/Dental Instruments |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.9B | 38.6B |
| IPO Year | 2003 | N/A |
| Metric | CHT | MDLN |
|---|---|---|
| Price | $43.18 | $44.04 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 23 |
| Target Price | N/A | ★ $50.48 |
| AVG Volume (30 Days) | 121.2K | ★ 5.3M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.02% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $5.37 | $10.88 |
| Revenue Next Year | $3.23 | $7.69 |
| P/E Ratio | ★ $26.66 | $658.75 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $39.28 | $38.50 |
| 52 Week High | $47.03 | $50.88 |
| Indicator | CHT | MDLN |
|---|---|---|
| Relative Strength Index (RSI) | 53.76 | 44.77 |
| Support Level | $41.94 | $43.04 |
| Resistance Level | $43.91 | $44.11 |
| Average True Range (ATR) | 0.53 | 1.45 |
| MACD | 0.02 | -0.42 |
| Stochastic Oscillator | 60.17 | 18.99 |
Chunghwa Telecom Co Ltd is Taiwan's integrated telecom operator, providing fixed-line, wireless, and Internet and data services. The company's reportable segments are: Consumer Business, Enterprise Business, International Business, and Others. The majority of its revenue comes from the Consumer Business, which focuses on individual and home-centric businesses, such as mobile, fixed broadband, Wi-Fi, IPTV (MOD), and OTT services. The Enterprise business offers IDC, cloud, cybersecurity, 5G, AIoT, data, AI, enterprise digital transformation, and system integration services to businesses, and the International business segment represents services offered to international customers. Geographically, the company generates maximum revenue from its business in Taiwan.
Medline is the largest medical-surgical products and supply chain solutions provider in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.